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Purpose: Cannabinoid receptors have been detected in neuron cells and proposed as potential therapeutic agents in
neurodegenerative disorders because of their involvement in controlling neural cell survival and death. However, their
presence and role in human retinal pigment epithelial (RPE) cells, which play a key role in initiating and developing age
related macular degeneration (ARMD), have never been investigated. Here we analyzed the expression of and changes
in cannabinoid receptors (CB1 and CB2) and one enzyme responsible for endocannabinoid hydrolysis, fatty acid amide
hydrolase (FAAH), in RPE cell oxidative damage process, a cellular model of ARMD.
Methods: Primary human RPE cells and cells from the ARPE-19 cell line were cultured and exposed to H2O2 for 24 h to
induce oxidative damage. Real time RT–PCR, immunofluorescent staining, and western blot methods were performed to
study the expression of and changes in CB1 and CB2 receptors, and FAAH. Cell viability and reactive oxygen species
(ROS) production were measured by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and a
dichlorofluorescein (DCF) assay, respectively. PI3K/Akt and ERK1/2 protein expression and activation of signaling
molecules were assessed by western blot analysis.
Results: By using real time RT–PCR, immunofluorescent staining and western blot methods, we showed that human RPE
cells express CB1, CB2, and FAAH. Meanwhile, oxidative stress can upregulate CB1 and CB2 receptor expression, and
downregulate FAAH expression. The CB1/CB2 receptor agonist, CP55,940, and the CB2 receptor agonist, JWH015
significantly protected RPE cells from oxidative damage. In addition, CP55,940 significantly reduced the levels of
intracellular ROS, strengthened oxidative stress-induced activation of PI3K/Akt and reduced activation of the ERK1/2
signal pathway.
Conclusions: The results demonstrate the expression and regulation of CB1 and CB2 receptors and FAAH in human RPE
cells. The modulation of cannabinoid receptor tone warrants consideration for future therapeutic strategies of ARMD.
The endocannabinoid system (ECS), a new intercellular
communication network, has been shown to play a crucial role
in neurodegenerative disorders' pathogenesis [1,2]. The ECS
consists of the following: the cannabinoid receptors, which
include  Cannabinoid  receptor  1  (CB1)/CB2  receptors  and
non-CB1/CB2 receptors; the endogenous ligands, primarily
anandamide (AEA) and 2-arachidonylglycerol (2-AG); the
enzymes responsible for the endogenous ligands' degradation,
notably fatty acid amide hydrolase (FAAH), and biosynthesis;
and the specific uptake mechanisms [3].
Both cannabinoid receptors subtypes, CB1 and CB2, are
abundantly expressed in neurons and can protect neurons from
oxidative  damage  [4].  Cannabinoid  receptor  induction  of
neuroprotection has been observed in animal models of some
neurodegenerative  disorders,  including  Alzheimer  disease
[5],  Huntington’s  disease  [6],  multiple  sclerosis  [7],  and
Parkinson disease [8]. However, the presence and regulation
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of  cannabinoid  receptors  in  retinal  neurodegenerative
disorders have been studied far less than those in brain and
other organ systems.
Age-related  macular  degeneration  (ARMD)  is  a  late-
onset neurodegenerative retinal disease, which predominates
in the elderly as a cause of irreversible and profound vision
loss  [9].  ARMD  shares  many  common  clinical  and
pathogenetic  properties  with  other  neurodegenerative
disorders. Currently, there is no ideal therapy to prevent or
cure ARMD. Intake of antioxidants is the only established
treatment for those with the atrophic or “dry” form of ARMD
[10].  Although  treatment  options  for  those  with  the
neovascular or “wet” form have increased recently, even these
treatments are largely ineffective for reversing existing visual
impairment  [11].  Thus,  the  development  of  strategies  for
preventing  ARMD  assumes  great  importance;  and  new
treatment approaches should focus on the initial insults that
lead to the disease's progression. ARMD initial pathogenesis
includes  degeneration,  dysfunction,  or  loss  of  RPE  cells
caused by oxidative injury [12].
Previous  studies  have  demonstrated  the  presence  of
endocannabinoids  (AEA  and  2-AG)  in  retinas  by  gas
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1243chromatography  and  mass  spectrometry  [13-15].  CB1
receptor, a cannabinoid receptor enriched in neuronal tissue,
was localized in the inner and outer plexiform layers of a
human retina [16]. Unlike CB1 receptor, CB2 receptor and
FAAH were undetectable in the human retina, but were found
in rat retina, mostly in the ganglion cells and in the soma of
dopamine amacrine cells and large cells [17,18]. The function
of ECS in the eye, in addition to regulating photoreception and
neurotransmission in the retina, and the effects on intraocular
pressure and ocular blood vessels [19-24], also encompasses
neuroprotective effects against retinal neurotoxicity [25,26].
This background suggests a functional ECS in the retina. Eyes
of patients with ARMD have been show increase levels of
endocannabinoids (AEA) in their retina [27]. Therefore, we
hypothesized that ECS, acting as a novel signaling system in
the  retina,  may  play  a  substantive  role  in  the  ARMD
pathophysiological  process.  Because  most  effects  of
endocannabinoids are mediated by binding to cannabinoid
receptors  and  terminated  by  degradation  enzyme  FAAH
[28]. Thus, the present study aims to examine the expression
of CB1 and CB2 receptors, and FAAH in human RPE cells,
and  their  changes  in  oxidative  stress  conditions,  using  a
cellular model of ARMD [29]. Our findings may set the basis
for the potential pharmacological modulation of cannabinoid
receptor tone as a novel therapeutic target in ARMD.
METHODS
Primary human RPE cells and ARPE-19 cell line culture:
Human RPE cells were obtained from eye bank donor eyes,
which were cut across the posterior pole, and the vitreous and
neural retina were removed. Eyes were obtained from three
male human donors between 30 and 50 years of age. None of
the donors had a known history of eye disease. The eyes at
time of receipt were all integral. RPE cells were isolated
within 4 to 16 h after death.The remaining eyecup was washed
with phosphate buffered saline (PBS, 8.00 g NaCl, 0.20 g KCl,
0.24 g KH2PO4 and 1.44 g Na2HPO4 in 1 l distilled water, pH
7.4)  and  incubated  with  0.025%  trypsin-ethylene  diamine
tetraacetic acid (EDTA; Invitrogen-Gibco, Carlsbad, CA) in
a humidified chamber at 37 °C. The cells then were scraped
gently and seeded in Dulbecco’s modified Eagle’s medium
(DMEM;  Invitrogen-Gibco)  containing  15%  fetal  bovine
serum (FBS; Invitrogen-Gibco).
A human retinal pigment epithelial cell line (ARPE-19)
was  purchased  from  American  Type  Culture  Collection
(ATCC;  Manassas,  VA).  The  cells  were  maintained  in
DMEM/F12 medium (Invitrogen-Gibco) supplemented with
10%  FBS  (Invitrogen-Gibco)  and  1%  penicillin  and
streptomycin, and were cultured at 37 °C in a humidified
atmosphere of 95% air and 5% CO2. The medium was changed
every two days. The ARPE-19 cells were used within 10
generations.  Since  cells  of  lower  generations  were  quite
sensitive to oxidative stress.
Cell  treatment:  The  ARPE-19  cells  were  seeded  in  flat-
bottomed microculture 96 well plate (15,000 cells/well) and
allowed  to  adhere  for  24  h.  Dose–response  assays  were
performed  on  the  ARPE-19  cells  to  determine  the  50%
inhibiting concentration (IC50) of hydrogen peroxide (H2O2).
The cells were treated with 0 to 500 μM H2O   in serum-free 2     
 and  phenol-free  DMEM-F12  medium for  24 h.  The 30%
H2O2  stock   solution  was  used   within  its  three-month
expiration limit. Working solutions of H2O2 were  made fresh
and added to the medium.
CP55,940 (Sigma, St. Louis, MO) is a nonselective CB1
and  CB2  cannabinoid  receptor  agonist.  ACEA  (Tocris
Bioscience,  Ellisville,  MO)  is  a  selective  CB1  agonist.
JWH015  (Cayman,  Ann  Arbor,  MI)  is  a  selective  CB2
receptor  agonist.  ARPE-19  cells  were  preincubated  with
various concentrations of CP55,940, ACEA, and JWH015 for
15 min before exposure to 200 μM H2O2 for 24 h in serum-
free, phenol-red-free DMEM and F12 media at 37 °C.
For each concentration of H2O2 and the compounds, five
wells were analyzed. Each experiment was performed at least
three times.
RNA extraction: Total RNA was isolated from primary human
RPE  cells,  ARPE-19  cells  and,  H2O2  (200  μM)-treated
ARPE-19 cells using the RNeasy Total RNA System (RNeasy
Mini Kit, Qiagen, Valencia, CA) following the manufacturer's
recommendation, and then treated with RNase-free DNase I
to remove any contaminating genomic DNA. The isolated
RNA had optic density (OD) 260/280 ratios greater than or
equal to 2.0 [30]. To synthesize a cDNA template for PCR,
we reverse transcribed 1 μg of total RNA with oligo-(dT)
primer and reverse transcriptase (ReverTra Ace, Toyobo Co.,
Ltd., Osaka, Japan). The quality of first-strand cDNA was
confirmed by PCR with β-actin primers.
Real-time reverse transcription-polymerase chain reaction
(Real-time RT–PCR): Real-time RT–PCR was performed for
quantitative analysis according to the standard protocol using
the SYBR Green PCR Master Mix (Toyobo Co., Ltd., Osaka,
Japan). PCR conditions for CB1 and CB2 were as follows:
after initial denaturation at 95 °C for 5 min, 40 cycles were
performed at 94 °C for 30 s, 58 °C for 30 s, and 72 °C for 1
min, followed by a 10 min extension at 72 °C. For FAAH, the
conditions were as follows: after initial denaturation at 95 °C
for 5 min, 40 cycles were performed at 94 °C for 30 s, 62 °C
for 30 s, and 72 °C for 1 min, followed by a 10 min extension
at 72 °C.
Primers  used  were  shown  in  Table  1.  Quantification
analysis of CB1, CB2, and FAAH mRNA was normalized with
β-actin as reference. The specificity of PCR amplification
products was checked by performing a dissociation melting
curve  analysis.  Relative  multiples  of  changes  in  mRNA
expression were determined with the relative comparative
threshold (CT) method.
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1244Immunofluorescent staining: CB1 and CB2 expression in the
ARPE-19  cells  was  determined  by  immunofluorescent
staining. In brief, ARPE-19 cells were grown to confluence in
chamber slides (Nalgene-Nunc, Lab-Tek, Naperville, IL). The
growth medium was aspirated and the cells were washed three
times with PBS, and then fixed with 4.0% paraformaldehye
for 20 min at 4 °C. After the cells had been washed with PBS,
they were permeabilized with 0.2% Triton X-100 in PBS for
15 min at room temperature. Subsequently, CB1 and CB2
expression  in  the  ARPE-19  cells  was  determined  by
immunofluorescent staining using a 1:100 dilution of anti-
CB1 (rabbit polyclonal, Abcam, Cambridge, UK) or anti-CB2
(rabbit polyclonal, Abcam), respectively, for 6 h at 4 °C. After
the cells had been rinsed with PBS, they were probed with
1:250 goat anti-rabbit FITC (Pierce, Rockford, IL) for 1 h at
room temperature. Their nucleus was counterstained with 4’,
6-diamidino-2-phenylindole (Molecular Probes, Invitrogen-
Gibco,  Carlsbad,  CA).  Images  were  obtained  with  a
fluorescent microscope (Olympus IX 81) at 20X objective
with 1.5X optical zoom (Olympus IX 81, Olympus Optical,
Tokyo, Japan).
MTT assay for cell viability: An 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl  tetrazolium  bromide  (MTT)  assay  is  a
qualitative index of cell viability. Mitochondrial and cytosolic
dehydrogenases of living cells reduce the yellow tetrazolium
salt (MTT) to produce a purple formazan dye that can be
detected spectrophotometrically [31]. After ARPE-19 cells
were preincubated with various concentrations of CP55,940,
ACEA, and JWH015 for 15 min followed by exposure to
200 μM H2O2 for 24 h. Then, MTT (Sigma, St. Louis, MO)
was added to a final concentration of 0.5 mg/ml and incubated
for 4 h at 37 °C. The culture medium was then removed and
the remaining blue precipitate was solubilized in dimethyl
sulfoxide, followed by reading absorbance at 570 nm in a plate
reader  using  630  nm  as  a  reference  (Spectra  Max  340;
Molecular  Devices,  Sunnyvale,  CA).  This  reading  was
divided by the adjusted absorbance reading of untreated cells
in control wells to obtain the percentage of cellular survival.
Reactive  oxygen  species  determination:  The  intracellular
reactive  oxygen  species  (ROS)  level  is  an  important
biomarker  for  oxidative  stress.  An  increased  ROS  level
generally indicates increased oxidative stress. Relative ROS
production was determined by the formation of a fluorescent
Dichlorofluorescein (DCF) compound on oxidation of the
nonfluorescent, reduced DCF-DA [32]. Cells were incubated
with 10 μM DCF-DA at 37 °C for 30 min, and then washed
twice with PBS. Relative fluorescence was measured using a
fluorescence plate reader at 485 nm excitation and 535 nm
emission wavelength (Wallace, Perkin-Elmer, Warrington,
UK).
TABLE 1. PRIMER SEQUENCES USED FOR REAL TIME RT–PCR.
Gene Primer (5′-3′)
CB1 F: TTCCCTCTTGTGAAGGCACTG
R: TCTTGACCGTGCTCTTGATGC
CB2 F: TTTGCTTTCTGCTCCATGCTG
R: TTCTTTTGCCTCTGACCCAAG
FAAH F: GCCTGGGAAGTGAACAAAGGGACC
R: CCACTACGCTGTCGCACTCCGCCG
β-actin F: GATGAGATTGGCATGGCTTT
R: GAGAAGTGGGGTGGCTT
Figure 1. Effect of H2O2 on cell viability
and morphological alterations. A: The
ARPE-19  cells  were  incubated  with
concentrations of 0–500 μM H2O2 for 24
h. Cell viability was determined by an
MTT  assay.  B:  Phase  contrast
photomicrographs  of  ARPE-19  cells.
ARPE-19 cells were treated with 0, 200
μM  H2O2,  1  μM  CP55,940,  1  μM
CP55,940 plus 200 μM H2O2 for 24 h
(Magnification: 100X).
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1245Western blot analysis: We plated the ARPE-19 cells into six-
well plates (150,000 cells/ml). To evaluate the expression of
CB1 and CB2 receptors and FAAH, we treated the cells with
200 μM H2O2 in serum-free and phenol-free DMEM and F12
medium for 24 h. As for the expression of PI3K/Akt and
ERK1/2 protein, the cells were pretreated with or without
1 μM CP55,940 for 15 min and then exposed to 200 μM
H2O2 for 24 h. After the treatment, the cells were rinsed twice
with ice-cold PBS, then scraped into cell lysis buffer and
centrifuged at 13400x g for 10 min at 4 °C. Protein levels were
determined using the bicinchoninic acid (BCA) protein assay
(Pierce). Next, 15 μg of total protein were solubilized in 2%
sodium dodecyl sulfate (SDS) sample buffer, separated on
10%  SDS-polyacrylamide  gel  by  electrophoresis  (SDS–
PAGE)  and  transferred  to  nitrocellulose  membranes  by
electroblotting. The blots were washed in Tris-buffered saline
containing 0.1% Tween-20 and 5% nonfat dairy milk, and
incubated in antibodies to 1:1000 dilution of rabbit polyclonal
CB1 and CB2 receptors antibodies (Abcam), 1:1,000 dilution
of  mouse  polyclonal  FAAH  antibody  (Abcam),  1:3,000
dilution of rabbit polyclonal PI3K/Akt and ERK1/2 antibodies
(Cell  Signaling  Technology,  Beverly,  MA),  and  1:10,000
dilution  of  mouse  monoclonal  GAPDH  antibody  (Cell
Signaling Technology) at 4 °C overnight. Blots were washed
three times, incubated with 1:3,000 horseradish peroxidase
(HRP)-conjugated goat anti-rabbit IgG (Pierce) or 1:20,000
HRP-conjugated goat anti-mouse IgG (Pierce) and developed
using  chemiluminescence  (SuperSignal  West  Pico
Luminescent;  Pierce)  according  to  the  manufacturer’s
instructions.
Statistical  analysis:  Data  were  presented  as  the  mean
±standard error of the mean (SEM) of the results of two or
three separate experiments, as specified in the figure legends.
Data were analyzed using ANOVA or a Student’s t-test with
the  SPSS  software.  A  p-value  <0.05  was  considered
significant.
RESULTS
Effect of H2O2 on ARPE-19 cell viability: The MTT assay for
cell viability was used to quantify the ARPE-19 cell cytotoxic
response to H2O2. H2O2 produced a progressive, cytotoxic
effect in the ARPE-19 cells, beginning at a dose of 100 μM,
with 5.7% cytotoxicity and reaching a maximum toxicity at
77.5%  damaged  cells  measured  at  500  μM  after  24  h  of
incubation  (p<0.05;  Figure  1).  The  results  indicate  that
treating ARPE-19 cells with H2O2 for 24 h caused a dose-
dependent decrease in their viability with the half maximal
inhibitory concentration (IC50) of 200 μM.
Expression  of  and  changes  in  cannabinoid  receptors  and
FAAH in RPE cells: As Figure 2A shows, real time RT–PCR
revealed primary human RPE cells expressed CB1, CB2, and
FAAH mRNA. ARPE-19 cells were treated with 200 μM
H2O2 for 24 h, and the changes in CB1, CB2, and FAAH
mRNA expression were determined by quantitative RT–PCR.
The results showed that H2O2-treated ARPE-19 cells had a
7.02  fold  increased  CB1  mRNA  expression,  a  5.68  fold
increased CB2 mRNA expression, and a 35.7 fold decreased
FAAH mRNA expression, compared to untreated cells (Figure
2B). Consistent with the results of RT–PCR, CB1 and CB2
protein expression increased and FAAH protein expression
decreased in 200 μM H2O2 -treated ARPE-19 cells (Figure
2C). Similar results were obtained with immunofluorescence
assays (Figure 2D).
CP55,940  attenuates  H2O2-induced  cytotoxicity  and  ROS
generation in ARPE-19 cells: As Figure 3A shows, 200 μM
H2O2 (24 h) induced a significant (42%) decrease in ARPE-19
Figure 2. Expression of CB1, CB2, and FAAH mRNA in human
primary RPE cells and changes of CB1, CB2, FAAH mRNA and
protein expression in 200 μM H2O2-treated ARPE-19 cells compared
to untreated ones. A: Expression of CB1, CB2, and FAAH mRNA
expression in human primary RPE cells assayed by real time RT–
PCR  method.  B:  Changes  of  CB1,  CB2,  and  FAAH  mRNA
expression in ARPE-19 cells assayed by real time RT–PCR method.
Asterisk (*) represents the correlation significant at the p<0.05 level
and suggest a significant increase or decrease in mRNA expression
as compared to control group. C: Changes of CB1, CB2, and FAAH
protein expression in ARPE-19 cells assayed by western blot method.
D:  Changes  of  CB1,  CB2  protein  expression  in  ARPE-19  cells
demonstrated by immunofluorescent staining.
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1246cell viability. Pretreating ARPE-19 cells with CP55,940 for
15 min significantly protected them against H2O2-induced
toxicity  at  concentrations  of  0.1,  0.3,  and  1  μM,  with,
respectively, 88%, 98%, and almost 100% of the control.
Treatment with H2O2 at 200 μM for 24 h induced a significant
increase  in  intracellular  ROS,  approximately  1.7  times
compared to the control. Pretreatment with 1 μM CP55,940
for  15  min  significantly  inhibited  ROS  generation  (23%
reduction; Figure 3B). ARPE-19 cells treated with 0, 0.01, 0.1,
and 1 μM CP55,940 alone showed no significant effect on
viability compared to the untreated control cells.
Figure 3. CP55,940 attenuates H2O2-induced cytotoxicity and ROS
generation.  A:  Protective  effects  of  CP55,940  on  H2O2-induced
decrease in cell viability measured by the MTT assay. Cells were
pretreated with 0–1 μM CP55,940 for 15 min before exposure to 200
μM H2O2 for 24 h, and cell viability was measured by MTT assay.
Asterisk (*) the correlation significant at the p<0.05 level and suggest
a significant increase in cell viability as compared to H2O2-treated
group. B: Protective effects of CP55,940 on H2O2-induced increase
in intracellular ROS in ARPE-19 cells. Cells were pretreated with 0–
1 μM CP55,940 for 15 min before exposure to 200 μM H2O2 for 24
h,  and  intracellular  ROS  was  measured  by  the  DCF-DA  assay.
Aterisk (*) represents the correlation significant at the p<0.05 level
and suggest a significant decrease in intracellular ROS generation as
compared to H2O2-treated group.
CP55,940  enhanced  H2O2-induced  activation  of  PI3K/Akt
and reduced activation of ERK1/2: To address the potential
role  of  PI3K/Akt  in  mediating  CP55,940  protection  of
ARPE-19  cells  from  oxidative  injury,  we  assessed
phosphorylation of PI3K/Akt by western blot analysis. The
results showed that PI3K/Akt is activated by H2O2. Pretreating
ARPE-19 cells with 1 μM CP55,940 followed by 200 μM
H2O2 enhanced PI3K/Akt activity compared to cells treated
with 200 μM H2O2 alone (Figure 4A). LY 294002, a specific
inhibitor of PI3K/Akt, was used to block PI3K/Akt activation.
ARPE-19 cells were pretreated with 20 μM LY294002 for 15
min in the presence or absence of CP55,940, followed by an
H2O2 challenge for 24 h. As Figure 4B shows, inhibition of
PI3K/Akt abrogated CP55,940 protection of ARPE-19 cells
from oxidative injury.
U0126, a specific inhibitor for the ERK1/2 pathway, was
used to evaluate whether ERK1/2 is involved in H2O2-induced
ARPE-19  cell  oxidative  damage.  ARPE-19  cells  were
pretreated  with  the  selective  inhibitor  for  ERK1/2  before
exposure to H2O2, and cell viability levels were determined.
Viability  levels  increased  significantly  in  the  presence  of
20  μM  U0126  (Figure  4C).  Because  of  that,  their
phosphorylated ERK1/2 (p-ERK1/2) level was examined by
western  blot  analysis,  which  showed  that  ERK1/2  was
activated by H2O2; pretreating ARPE-19 cells with CP55,940
reduced p-ERK1/2 activity, compared to cells treated with
H2O2 alone (Figure 4A).
CB2 receptor agonist attenuates H2O2-induced cytotoxicity in
ARPE-19 cells: As Figure 5 shows, pretreating ARPE-19 cells
with JWH015, a CB2 receptor agonist, for 15 min resulted in
a  significant  protection  against  H2O2-induced  toxicity  at
concentrations of 0.1, 1, 5, and 10 μM, with, respectively,
62%, 68%, 86%, and 95% of the control. Pretreatment with
CB1  receptor  agonist  (AECA)  for  15  min  showed  no
cytoprotective effect (Figure 5).
DISCUSSION
To the best of our knowledge, this is the first demonstration
of the presence of CB1, CB2, and FAAH in human RPE cells,
which play a key role in ARMD initiation and development.
Plenty of evidence in the previous literature suggests that
oxidative stress is a contributing factor to RPE dysfunction in
ARMD  [33].  The  results  led  us  to  further  analyze  the
cannabinoid receptors and FAAH expression changes in RPE
cells induced by oxidative stress. Most studies have used
human RPE cells as the in vitro study model of ARMD, either
primary or cell line. One of the drawbacks of using primary
RPE cells is that it provides a limited number of cells and may
lack a consistent cellular background. The ARPE-19 cell line
overcomes this problem while maintaining the morphological
and functional characteristics of primary cells. In addition,
ARPE-19  cells  respond  to  oxidative  stress  (H2O2,  media
starvation, etc.) in a fashion similar to that of primary cultured
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1247human RPE cells. Therefore, we have used the ARPE-19 cell
line for most of our studies. H2O2 added to the culture medium
was used as a chemical oxidant. This agent is convenient and
biologically relevant, especially for the RPE cells. H2O2 has
been found in ocular tissues in vivo [34] and can be produced
by the RPE cells as a reactive oxygen intermediate during
photoreceptor  outer  segment  phagocytosis  [35].  For  these
reasons, we selected H2O2 for our studies and performed a
series  of  dose  response  assays  to  determine  the  working
concentration that led to a consistent and reliable cytotoxicity.
By using real-time RT–PCR and the western blot method,
we showed that oxidative stress can upregulate CB1 and CB2
receptor expression and downregulate FAAH expression in a
cell model of ARMD. These results agree with a previous
Figure 4. CP55,940 modulates phosphorylation of PI3K/Akt and
ERK1/2. A: Representative western blot analysis shows that 1 μM
CP55,940 enhanced H2O2-induced activation of p-PI3K/Akt and
reduced activation of p-ERK1/2 in ARPE-19 cells. B: Protective
effects of PI3K/Akt inhibitor (LY294002) on H2O2-induced decrease
in cell viability measured by the MTT assay. ARPE-19 cells were
pretreated with or without 20 μM LY294002 for 15 min in the
presence or absence of 1 μM CP55,940 before exposure to 200 μM
H2O2 for 24 h. Asterisk (*) represents the correlation significant at
the p<0.05 level and suggest a significant increase in cell viability as
compared  to  H2O2-treated  group.  Hash  mark  (#)  represents  the
correlation significant at the p<0.05 level and suggest a significant
decrease in cell viability as compared to CP55,940+H2O2-treated
group. C: Protective effects of selective ERK1/2 inhibitor (U0126)
on H2O2-induced decrease in cell viability measured by the MTT
assay. ARPE-19 cells were pretreated with 20 μM U0126 for 15 min
before exposure to 200 μM H2O2 for 24 h Asterisk (*) represents the
correlation significant at the p<0.05 level and suggest a significant
decrease in cell viability as compared to control group. Asteriks and
hash mark (#) represents the correlation significant at the p<0.05
level and suggest a significant increase in cell viability as compared
to H2O2-treated group. Data are expressed as mean±SEM of results
in  three  separate  experiments,  each  experiment  performed  in
duplicate.
comparative  analytical  study,  which  showed  that
endocannabinoids (AEA) increased in the retina from human
ARMD eyes [27]. As a lipid soluble substance, AEA cannot
be stored in vesicles; and therefore it is synthesized on demand
and travels, in a retrograde direction, across the postsynaptic
membrane to the presynaptic membrane, where it activates
presynaptic  CB1  and  CB2  receptors  [36].  After  cellular
uptake,  AEA  is  degraded  via  the  enzyme  FAAH  [14].
Variation  of  ECS  also  can  be  observed  in  other
neurodegenerative  disorders,  such  as  Parkinson  disease,
Alzheimer  disease,  and  multiple  sclerosis  [2,37,38].  The
variation of ECS may be an endogenous response to maintain
endocannabinoid  homeostasis  and  regulate  the  pathologic
function  of  neuron  cells  [39,40].  In  line  with  the
endocannabinoid homeostasis theory, there are now several
Figure  5.  JWH015,  but  not  ACEA,  attenuates  H2O2-induced
cytotoxicity. A: Inhibition of H2O2-induced decrease in ARPE-19
cell viability by JWH015. ARPE-19 cells were pretreated with 0–10
μM JWH015 for 15 min before exposure to 200 μM H2O2 for 24 h,
and their viability was measured by the MTT assay. Asterisk (*)
represents the correlation significant at the p<0.05 level and suggest
a significant increase in cell viability as compared to H2O2-treated
group. B: ACEA showed no significant effect on H2O2-induced
decrease in cell viability. ARPE-19 cells were pretreated with 0–10
μM ACEA for 15 min before exposure to 200 μM H2O2 for 24 h, and
their viability was measured by MTT assay.
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1248examples of the successful use of ECS-directed drugs used to
alleviate the clinical symptoms of neurodegenerative diseases
in  animal  models  [2,41,42].  These  results  suggest  that
cannabinoid receptors may be potential targets for therapeutic
interventions for ARMD.
We also introduced CP55,940, which is a nonselective
CB1/CB2 receptor agonist in oxidative stress-induced RPE
cellular damage. We found that CP55,940 protected ARPE-19
cells  from  oxidative  stress-induced  cell  damage  and
intracellular ROS generation in a dose-dependent way with
excellent efficacy. We further explored whether CP55,940
induced  cytoprotective  signaling  pathways  while  rescuing
RPE  cells  from  oxidative  damage.  The  PI3K/Akt-  and
ERK1/2-mediated  survival  signal  pathways  had  been
suggested to protect RPE cells from oxidative stress [43,44].
We therefore addressed whether CP55,940 could modulate
PI3K/Akt and ERK1/2 pathways, and found that CP55,940
could  enhance  H2O2-induced  activation  of  PI3K/Akt  and
reduce the activation of the ERK1/2 pathway. We further
investigated whether the selective activation of CB1 or CB2
receptor could protect RPE cells from oxidative stress induced
damage. We used a cell viability assay to determine viability
in cells treated with H2O2. We demonstrated that CB2 receptor
agonist, but not CB1 receptor agonist, significantly protected
human RPE cells from oxidative stress. Several studies have
shown CB1 receptor activation to mediate neuroprotection,
but this is not a universal finding [45,46]. This neuroprotective
effect could be related to different cell types and pathological
conditions.
In conclusion, we demonstrated the expression of CB1
and CB2 receptors and FAAH in human RPE cells, and their
changes in oxidative stress conditions. The RPE cells perform
vital functions for safeguarding photoreceptor cells against
oxidative  stress  and  are  involved  in  the  pathogenesis  of
ARMD [47]. These findings open up the attractive possibility
that  a  correlation  exists  between  endocannabinoid
homeostasis and the onset of ARMD. However, as we observe
inhibition, rather than the more usual stimulation, of ERK
signaling, the involvement of receptors other than CB1 as well
as CB2 in the effects of CP55,940 or JWH015 cannot be
excluded. More studies using siRNA or specific CB1 and CB2
receptor antagonists should be performed to examine whether
manipulating the levels of cannabinoid receptors could be a
novel pharmacological approach to treat ARMD in the future.
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